TP53 and cancer: In addition, other markers related to proliferation, disruption in cell cycle regulation, cancer development, progression, and malignant transformation such as the expression of KI-67, p16 and p53, COX-2, Annexin A1, etc., have been tested in the prediction models and need to be formally validated [41,47,108,117].